Comparing Apixaban vs Edoxaban
| Apixaban | Edoxaban |
|
|---|
| Apixaban | Edoxaban |
|
|---|---|---|
|
Prescription only
Apixaban reduces the clotting ability of the blood and is used in the treatment and prevention of several medical conditions associated with blood clots. It does not require monitoring; and an... View more |
Prescription only
Prescribed for Atrial Fibrillation, Prevention of Thromboembolism in Atrial Fibrillation, Pulmonary Embolism, Deep Vein Thrombosis. Edoxaban may also be used for purposes not listed in this medication guide. View more |
|
| More about Apixaban | More about Edoxaban | |
| Ratings & Reviews | ||
|
Apixaban has an average rating of 5.1 out of 10 from a total of 287 ratings on Drugs.com. 34% of reviewers reported a positive effect, while 41% reported a negative effect. |
Edoxaban has an average rating of 3.4 out of 10 from a total of 5 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 60% reported a negative effect. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
View all Apixaban side effects |
View all Edoxaban side effects |
|
| Drug Class | ||
| Generic Availability | ||
|
N/A |
N/A |
|
| Pricing and Coupons * Prices are without insurance | ||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | ||
|
N/A |
N/A |
|
| Brand Names | ||
| Eliquis, Eliquis Sprinkle | Savaysa | |
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
|
12 hours |
14 hours |
|
| CSA Schedule 1 View glossary of CSA terms | ||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | ||
|
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
|
| Drug Interactions | ||
|
A total of 401 drugs are known to interact with Apixaban:
|
A total of 285 drugs are known to interact with Edoxaban:
|
|
| Alcohol/Food/Lifestyle Interactions | ||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
| Disease Interactions | ||
| First Approval Date | ||
|
December 28, 2012 |
January 08, 2015 |
|
| WADA Class View classifications | ||
|
N/A |
N/A |
|
| More Information | ||
| Patient Resources | ||
| Professional Resources | ||
| Related Treatment Guide | ||
|
||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Eliquis
Eliquis is used to reduce the risk of stroke and systemic embolism in patients with nonvalvular ...
Xarelto
Xarelto (rivaroxaban) is a factor Xa inhibitor used to reduce the risk of blood clots and stroke in ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Lovenox
Lovenox is used to prevent deep vein thrombosis (DVT) which can lead to blood clots in the lungs ...
Pradaxa
Pradaxa (dabigatran) is used to prevent stroke and blood clots in patients with atrial ...
Heparin Sodium
Heparin Sodium is used for angina, anticoagulation during pregnancy, antiphospholipid syndrome ...
Fondaparinux
Fondaparinux is used for deep vein thrombosis, deep vein thrombosis prophylaxis after abdominal ...
Edoxaban
Edoxaban is used for atrial fibrillation, deep vein thrombosis, prevention of thromboembolism in ...
Dabigatran
Dabigatran is used for deep vein thrombosis, deep vein thrombosis, prophylaxis, deep vein ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.